Inhibition of the biological behaviors of MCF-7 cell line and tumor growth of nude mice model by RhoA siRNAMA Ji, XUE Yan, WANG Peng, LIU Wen-chao1057-1061
Expressions of VEGF and bFGF in human hepatocarcinoma cell with glaucescent fissistigma root injectionZUO Xiao-dong, CUI Yong-an, QIN Shu-kui, ZHANG Rui1062-1065
The KIF4A expression and prognostic significance in non-small cell lung cancerHAO Ke-ke, ZHAN Ping, WANG Qin1066-1069
Expression of BRCA1 and the correlation with chemotherapy and prognosis in non-small cell lung cancer after surgeryZENG Wei, SHAN Li, Patiguli, HAN Zhi-gang, LIU Li, MA Ling, WANG Qiang, ZHANG Yan1070-1073
Expression and clinical significance of RhoC and LyGDI in lung squamous cell cancer and adenocarcinomaQIN Hua-long, MA Hai-tao, HUANG Hai-tao, SONG Xin-yu1074-1077
Expression of osteopontin and NF-κB/p65 in breast caner and its clinical significanceXIE Hua, ZHENG Rong-sheng, GE Xia, ZHANG Hua-man1078-1082
Preliminary study on the clinical effect of nerve sparing radical hysterectomy for cervical cancerLONG Ying, YAO De-sheng, GAO Kun, LI Li, XIE Xiao-lan1083-1088
Clinical study of paclitaxel combined with capecitabine as first-line treatment for advanced gastric cancerGU Jian-chun, ZHENG Lei-zhen, ZHANG Li, CHEN Si-yu, LI Xiao-ping1089-1091
Comparison of 2-week regimen and 3-week regimen based on oxaliplation plus 5-flurouracil and leucovorin as first-line therapy for advanced gastric cancerFAN Cui-zhen, DAI Hong, CHU Yu-ping1092-1095
Retrospective analysis of prognostic factors and adjuvant chemotherapy for 189 cases of stage Ⅱ gastric cancer patients after radical operationRUAN Dan-yun, QIU Miao-zhen, LUO Hui-yan, ZHOU Zhi-wei, LI Wei, ZHAN You-qing, XU Rui-hua1096-1102
